Cognitive Improvement Through tDCS for Patients With Multiple Sclerosis (MS-CICS)
Multiple Sclerosis
About this trial
This is an interventional treatment trial for Multiple Sclerosis
Eligibility Criteria
Inclusion Criteria:
- diagnosis of multiple sclerosis.
- no acute inflammation during the last 3 months before the experimental intervention.
- no cortisol treatment during the last 3 months before the experimental intervention.
- stable medication during the experimental intervention.
- unrestrained or corrected visual ability.
- ability to read and write short german sentences.
- adequate motor ability to give responses on a keyboard.
- German as main language.
Exclusion Criteria:
- major depressive symptoms or any further neurological and/or psychiatric disease at experimental intervention.
- standard tDCS exclusion criteria (e.g. cardiac pacemaker, metal implants in head region, etc.)
Sites / Locations
- University Medicine Greifswald
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Sham Comparator
Sham Comparator
Anodal transcranial direct current stimulation
Cathodal transcranial direct current stimulation
Sham transcranial direct current stimulation for anodal group
Sham transcranial direct current stimulation for cathodal group
Patients will be bilaterally stimulated with anodal tDCS at the parietal cortex (Brodmann Area 7).
Patients will be bilaterally stimulated with cathodal tDCS at the parietal cortex (Brodmann Area 7).
Patients will be bilaterally stimulated with sham tDCS at the parietal cortex (Brodmann Area 7). As a consequence of the crossover design, both experimental arms receive sham stimulation.
Patients will be bilaterally stimulated with sham tDCS at the parietal cortex (Brodmann Area 7). As a consequence of the crossover design, both experimental arms receive sham stimulation.